Literature DB >> 1951997

Comparison of high and low doses of suxamethonium.

K G Stewart1, P M Hopkins, S G Dean.   

Abstract

In a double-blind study, 67 young adult patients undergoing anaesthesia for dental extractions were allocated at random to receive either 0.5 mg/kg or 1.5 mg/kg suxamethonium. A greater increase in arterial pressure was seen following induction in the 1.5 mg/kg group, although overall intubating conditions were similar in the two groups. Suxamethonium-associated muscle pains were significantly more common in the group which received the larger dose (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1951997     DOI: 10.1111/j.1365-2044.1991.tb09595.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  5 in total

1.  The optimal succinylcholine dose for intubating emergency patients: retrospective comparative study.

Authors:  Alaa Ezzat; Essam Fathi; Ahmad Zarour; Rajvir Singh; M Osama Abusaeda; M Magdy Hussien
Journal:  Libyan J Med       Date:  2011-07-14       Impact factor: 1.657

2.  Intubating conditions following rapid sequence induction with three doses of succinylcholine.

Authors:  Smita Prakash; Sushma Barde; Preeti Thakur; Anoop Raj Gogia; Rajvir Singh
Journal:  Indian J Anaesth       Date:  2012-03

3.  Modified electroconvulsive therapy in a patient with gastric adenocarcinoma and metastases to bone and liver.

Authors:  Gennie Wang; Brian Milne; Rachel Rooney; Tarit Saha
Journal:  Case Rep Psychiatry       Date:  2014-09-16

Review 4.  Optimal dose of succinylcholine for laryngeal mask airway insertion: systematic review, meta-analysis and metaregression of randomised control trials.

Authors:  Alan Hsi-Wen Liao; Yu-Cih Lin; Chyi-Huey Bai; Chien-Yu Chen
Journal:  BMJ Open       Date:  2017-08-04       Impact factor: 2.692

5.  The optimal dose of succinylcholine for rapid sequence induction: a systematic review and meta-analysis of randomized trials.

Authors:  Alessandro Putzu; Martin R Tramèr; Maxim Giffa; Christoph Czarnetzki
Journal:  BMC Anesthesiol       Date:  2020-03-02       Impact factor: 2.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.